Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
13 17 Search
2025
CELSR3 can serve as a diagnostic and prognostic biomarker for kidney renal clear cell carcinoma
Asian Journal of Surgery
2025
Emerging roles of EGFL family members in neoplastic diseases: Molecular mechanisms and targeted therapies
Biochemical Pharmacology
2023
Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
Scientific Data
2023
Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma
BMC Genomics
2022
Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma
Frontiers in Molecular Biosciences
2022
Evaluated expression of CELSR3 in oral squamous cell carcinoma is associated with perineural invasion and poor prognosis
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
2022
Clinical Significance and Underlying Mechanisms of CELSR3 in Metastatic Prostate Cancer Based on Immunohistochemistry, Data Mining, andIn SilicoAnalysis
Cancer Biotherapy and Radiopharmaceuticals
2021
Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer
Journal of Ovarian Research
2021
A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses
Genetic Testing and Molecular Biomarkers
2021
Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma
Bioscience Reports
2021
Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma
Journal of Cellular and Molecular Medicine
2020
Profiles of immune infiltration and its relevance to survival outcome in meningiomas
Bioscience Reports
2020
The Emerging Role of Adhesion GPCRs in Cancer
ACS Pharmacology & Translational Science
Additional cited-by details will be shown when available from Crossref